STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] Theratechnologies Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Summer Road LLC filed a Schedule 13G reporting beneficial ownership of 2,683,591 Common Shares of Theratechnologies Inc. (CUSIP 88338H704), representing 5.84% of the 45,980,019 shares outstanding cited from the issuer's Form 20-F. The Reporting Person is a Delaware family office that holds these shares through investment management agreements with two Family Clients, identified as Cap 1 LLC and East River Partners Ltd. The filing states the shares are held passively and were not acquired to influence control of the issuer.

Positive
  • Transparent disclosure of a material 5.84% stake (2,683,591 shares)
  • Identification of underlying holders (Cap 1 LLC and East River Partners Ltd.) improves investor clarity
  • Reporting Person states passive intent, reducing immediate governance/activism concerns
Negative
  • None.

Insights

TL;DR: A family office reports a passive stake of 5.84% in Theratechnologies, disclosing beneficial owners and voting/dispositive power.

The Schedule 13G shows Summer Road LLC controls 2,683,591 shares with sole voting and dispositive power, indicating consolidated management of these holdings through IMAs with Family Clients. Disclosure under Rule 13d-1(c) signals a passive intent rather than an activist stance, which typically reduces near-term governance risk for existing management while creating a meaningful minority ownership position that could attract investor attention.

TL;DR: Material passive ownership disclosed; names of underlying family clients are provided for transparency.

The filing identifies the Reporting Person as a family office operating under the Family Office Rule and names two Family Clients holding the shares. This level of disclosure improves transparency about who holds a material stake (>5%) and clarifies that voting/dispositive authority rests with the Reporting Person, which is relevant for governance monitoring but does not indicate an intent to change control.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Summer Road LLC
Signature:/s/ Frank S. Vellucci
Name/Title:Frank S. Vellucci, General Counsel
Date:09/29/2025

FAQ

How many Theratechnologies (THTX) shares does Summer Road LLC report owning?

The filing states Summer Road LLC beneficially owns 2,683,591 Common Shares.

What percentage of THTX does the reported stake represent?

The shares represent 5.84% of the 45,980,019 Common Shares outstanding cited in the filing.

Does Summer Road LLC intend to influence control of Theratechnologies?

The certification in the Schedule 13G states the shares were not acquired and are not held to change or influence control; the filing is consistent with passive ownership.

Who are the underlying beneficial owners mentioned in the filing?

The filing identifies two Family Clients as beneficial owners: Cap 1 LLC and East River Partners Ltd.

What authority does Summer Road LLC have over these shares?

The filing reports Summer Road LLC has sole voting and sole dispositive power over the 2,683,591 shares.
Theratechnologies Inc

NASDAQ:THTX

THTX Rankings

THTX Latest News

THTX Latest SEC Filings

THTX Stock Data

155.87M
34.79M
1.15%
45.49%
0.46%
Biotechnology
Healthcare
Link
Canada
Montreal